Moreover, TIMP2 could prevent the activation of tyrosine kinase receptors in tumor cells, including focal adhesion kinase [58], AKT [59] and epithelial growth factor receptor [60], which played key roles in tumor migration and growth. The gene discussed is AKT1; the disease is neoplasm.